Clinical trials
Pneumonia clinical trials
Below are recruiting pneumonia clinical trials, each written for real people, not researchers. We’re tracking 244 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06624540Recruiting
Reducing pneumonia in ICU patients through evidence-based nursing
This trial tests whether teaching nurses proven methods can lower the rate of ventilator-associated pneumonia (a lung infection from breathing machines) in intensive care. It aims to improve care for patients on ventilators.
DhakaAges 18 years+ - NCT06602557RecruitingPhase 2
Inhaled antibiotic for lung infection during ECMO support
This trial tests whether adding an inhaled antibiotic (amikacin) to standard IV antibiotics can better treat a serious lung infection (pneumonia caused by Gram-negative bacteria) in patients on a heart-lung machine (ECMO) and a breathing tube. If you or your loved one is on ECMO and has this type of pneumonia, this study may offer a new treatment approach.
ParisAges 18 years+ - NCT06602934Recruiting
Pneumonia, heart health, and your body's germs
This study looks at how pneumonia affects the long-term health of your heart and lungs by studying the germs that live in your body. It may help doctors understand why some people get worse and how to better protect your heart after a serious infection.
AngersAges 18–80 - NCT06607055Recruiting
Immune markers in ICU patients with pneumonia
This study looks at how the immune system reacts in ICU patients on a ventilator who have pneumonia. By measuring immune markers, the researchers hope to better understand and predict complications like ventilator-associated pneumonia.
Aix-en-ProvenceAges 18 years+ - NCT06566898Recruiting
Tracking antibiotic resistance in pneumonia patients
This study uses advanced genetic testing to monitor antibiotic-resistant bacteria in people with pneumonia. It aims to understand how resistance develops and improve treatment choices.
Shanghai, Shanghai MunicipalityAges Any age - NCT06554327Recruiting
Rapid test for lung infection in ICU patients on a ventilator
This trial uses a rapid test (PCR) to check for bacteria in your lung fluid, so doctors can pick the right antibiotics faster. It's for ICU patients on a breathing machine who may have a lung infection.
ReimsAges 18 years+ - NCT06269900RecruitingPhase 3
Dexamethasone for Severe Hospital-Acquired Pneumonia with Inflammation
This trial tests whether adding the anti-inflammatory drug dexamethasone to standard antibiotics improves recovery from severe hospital-acquired pneumonia in critically ill patients on a ventilator.
AmiensAges 18–85 - NCT06229288RecruitingPhase 3
Pneumonia treatment: amoxicillin alone vs. with clavulanate for adults 65+
This trial compares two antibiotics for older adults hospitalized with pneumonia. It aims to see if amoxicillin alone works as well as amoxicillin combined with clavulanate, which might reduce side effects.
Saint-Nazaire, FranceAges 65 years+ - NCT06123650Recruiting
Magnetic brain stimulation plus therapy for swallowing after stroke
This study tests whether adding a gentle magnetic brain stimulation (called rTMS) to standard swallowing therapy can help prevent pneumonia in people who have trouble swallowing after a stroke. It might reduce the risk of getting a lung infection.
Giza, Giza GovernorateAges 49–65 - NCT06087536RecruitingPhase 2
Trial of OMN6 for hospital-acquired Acinetobacter pneumonia
This trial tests a new antibiotic called OMN6 for people with a serious lung infection (pneumonia) caught in the hospital or from a breathing machine, caused by a hard-to-treat bacteria (Acinetobacter). The goal is to see if OMN6 is safe and how the body processes it.
AthensAges 18–99 - NCT06092008Recruiting
New pneumonia tests for adults 65 and older
This study tests new ways to diagnose pneumonia faster and more accurately in older adults who come to the emergency room with breathing problems. The goal is to see if these new tests work better than the current methods.
Columbus, OhioAges 65 years+ - NCT05848713RecruitingPhase 3
Blood-thinner treatment for complications of community pneumonia
This Phase 3 trial tests whether an anti-clot “blood thinner” can reduce complications from community-acquired pneumonia in hospitalized adults who need extra oxygen. It may help by lowering harmful clot-related effects during serious lung infection.
Chicago, IllinoisAges 18 years+ - NCT05843786RecruitingPhase 3
Interferon gamma for ventilator pneumonia in ICU
This trial tests whether a medicine called interferon gamma can improve outcomes in adults with a first episode of pneumonia that develops after being on a ventilator in the ICU. It is designed for specific ICU timing, infection severity, and immune marker levels, and it compares treatment on top of standard care.
LimogesAges 18 years+ - NCT05722938RecruitingPhase 3
Testing Trimodulin for severe pneumonia on breathing support
This trial tests an investigational medicine called Trimodulin (BT588) for people with severe pneumonia who need a breathing machine. The goal is to see if it helps them recover faster.
Mobile, AlabamaAges 18 years+ - NCT05719259Recruiting
Study on pneumonia from breathing machines in the ICU
This study watches patients in the intensive care unit (ICU) who are on a breathing machine (ventilator) to learn more about pneumonia that can happen from the machine. The goal is to understand how to better prevent and treat this infection.
TiranaAges 18 years+ - NCT05117125Recruiting
Testing for markers in early ventilator lung infections
This study looks at changes (biomarkers) in the blood or other samples from people on a breathing machine. It may help doctors detect ventilator-associated pneumonia earlier and tailor treatment sooner.
DrammenAges 18 years+ - NCT04681339Recruiting
Antibiotics in hospitalized children with community pneumonia
This study looks at how antibiotics are prescribed for children who are hospitalized with community-acquired pneumonia. It may help doctors choose more appropriate antibiotic use for kids in the hospital.
Filderstadt, Baden-WurttembergAges 3 months–18 years - NCT02139163Recruiting
Study of community-acquired pneumonia symptoms and X-ray findings
This study looks at adults with community-acquired pneumonia, using symptom checks and chest X-ray results. It may help researchers better understand what pneumonia looks like in the community and how it progresses.
HanoverAges 18 years+ - NCT00077909Recruiting
Study of Lung Proteins in Patients With Pneumonia
This research study examines proteins in fluid collected from your lungs during a breathing tube procedure (bronchoscopy) to better understand pneumonia. By studying these proteins, researchers hope to improve how doctors diagnose and treat lung infections.
Bethesda, MarylandAges 3–99 - NCT07854730Recruiting
Lung treatment with positioning for pneumonia in ventilated patients
This study tests whether using a breathing bag to inflate the lungs while changing body position can improve oxygen levels in patients with pneumonia who are on a breathing machine. It may help clear mucus and improve breathing.
CairoAges 40–60 - NCT04538937Recruiting
Study of high eosinophils causing lung/airway damage
This registry study looks at adults with high eosinophils (a type of immune cell) that are believed to be causing damage in the airways or lungs. It aims to better identify these eosinophils and understand what is going on so future treatments can improve.
InnsbruckAges 18 years+ - NCT00901602Recruiting
Study of invasive pneumococcal infections in Lebanon
This study collects laboratory samples from patients with invasive pneumococcal infections to learn about the germ and where it spreads. It may help doctors and public health teams track infection patterns and improve prevention and treatment planning.
BeirutAges 1 day+ - NCT05582512Recruiting
Study of long-term effects in children after COVID-19
This study looks at what long-term health effects children may have after getting COVID-19, and how those effects change over time. You may be asked to share health information and possibly complete a scan that can’t be done if certain metal is present.
Taipei, Chung Cheng DistrictAges Up to 18 years - NCT06145841Recruiting
Gene test to guide infection treatment in AIDS
This study is for people with HIV/AIDS who develop severe pneumonia or septic shock. It uses a special genetic test (metagenomic next-generation sequencing) to find the exact germ causing the infection so doctors can choose the right antibiotic.
Guangzhou, GuangdongAges 18–65
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pneumonia?
- Yes. Clin2 currently lists 244 recruiting pneumonia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pneumonia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pneumonia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.